BIOMARIN PHARMACEUTICAL INC — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
305B2
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12G
8-A12G/A
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
PREC14A
PREM14A
PRER14A
PRRN14A
RW
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-25-173541 | Aug 5, 2025 | — |
| 8-K | 8-K | 0001048477-25-000088 | Aug 4, 2025 | — |
| 8-K | 8-K | 0001048477-25-000086 | Aug 1, 2025 | Jul 30, 2025 |
| SC TO-T/A | SC TO-T/A | 0001193125-25-153574 | Jul 1, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-141753 | Jun 17, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-140825 | Jun 13, 2025 | — |
| CORRESP | — | 0001193125-25-140835 | Jun 13, 2025 | — |
| SC TO-T/A | SC TO-T/A | 0001193125-25-134942 | Jun 4, 2025 | — |
| SC TO-T | SC TO-T | 0001193125-25-132730 | Jun 2, 2025 | — |
| 4 | FORM 4 | 0001048477-25-000072 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000074 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000076 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000078 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000080 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000066 | May 22, 2025 | May 20, 2025 |
| 8-K | 8-K | 0001193125-25-125040 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000068 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000064 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000070 | May 22, 2025 | May 20, 2025 |
| 4 | FORM 4 | 0001048477-25-000062 | May 22, 2025 | May 20, 2025 |
| 144 | — | 0001959173-25-003343 | May 20, 2025 | — |
| 4 | FORM 4 | 0001048477-25-000060 | May 20, 2025 | May 19, 2025 |
| SC TO-C | SC TO-C | 0001193125-25-122547 | May 19, 2025 | — |
| SC TO-C | SC TO-C | 0001193125-25-121891 | May 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-121296 | May 16, 2025 | — |
| SC TO-C | SC TO-C | 0001193125-25-121299 | May 16, 2025 | — |
| SC TO-C | SC TO-C | 0001193125-25-121809 | May 16, 2025 | — |
| SCHEDULE 13G/A | — | 0001422848-25-000069 | May 13, 2025 | — |
| 4 | FORM 4 | 0001048477-25-000053 | May 6, 2025 | May 2, 2025 |
| 10-Q | 10-Q | 0001048477-25-000051 | May 2, 2025 | Mar 31, 2025 |
| 144 | — | 0001959173-25-002807 | May 2, 2025 | — |
| 8-K | 8-K | 0001048477-25-000049 | May 1, 2025 | — |
| SCHEDULE 13G/A | — | 0002052113-25-001848 | Apr 29, 2025 | — |
| DEF 14A | DEF 14A | 0001048477-25-000045 | Apr 8, 2025 | May 20, 2025 |
| DEFA14A | DEFA14A | 0001048477-25-000047 | Apr 8, 2025 | — |
| ARS | ANNUAL REPORT TO SECURITY HOLDERS | 0001308179-25-000412 | Apr 8, 2025 | Dec 31, 2024 |
| 4 | FORM 4 | 0001048477-25-000041 | Mar 20, 2025 | Mar 19, 2025 |
| 144 | — | 0001959173-25-002159 | Mar 19, 2025 | — |
| 4 | FORM 4 | 0001048477-25-000033 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001048477-25-000027 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001048477-25-000035 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001048477-25-000031 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001048477-25-000037 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001048477-25-000029 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001048477-25-000039 | Mar 18, 2025 | Mar 14, 2025 |
| 4 | FORM 4 | 0001048477-25-000025 | Mar 7, 2025 | Mar 6, 2025 |
| 3/A | FORM 3/A | 0001048477-25-000023 | Mar 7, 2025 | Feb 24, 2025 |
| 144 | — | 0001959173-25-001779 | Mar 6, 2025 | — |
| 4 | FORM 4 | 0001048477-25-000021 | Mar 4, 2025 | Feb 28, 2025 |
| 8-K | 8-K | 0001193125-25-044103 | Mar 3, 2025 | Feb 25, 2025 |